Carpo, Analin .

HRN: 21-90-35  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2025
CEFUROXIME 1.5GM (VIAL)
12/26/2025
12/27/2025
IV
1.5g
PTOR
Elective CS
Checking Initial Appropriateness 
12/26/2025
CEFUROXIME 1.5GM (VIAL)
12/26/2025
12/27/2025
IV
1.5gms
Q8hrs X 3 Doses
S/P Primary CS + BTL
Checking Initial Appropriateness 
12/26/2025
CEFUROXIME 500MG (TAB)
12/27/2025
01/03/2026
PO
500mg
BID X 7 Days
S/P Primary CS + BTL
Checking Initial Appropriateness 
12/26/2025
MUPIROCIN 2%, 15G (TUBE)
12/26/2025
01/09/2026
TOPICAL
15gms
OD X 14 Days
S/P Primary CS + BTL
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: